Maningitis, commonly known as brain fever, is a serious condition that affects the lining of the brain and spinal cord. One of the most dangerous forms of the disease is, caused by a bacteria called Neeseria meningitidis. Meningococcal vaccine provides targeted protection against this bacteria, which spreads closely and through prolonged contact with respiratory drops from an infected person.

Meningococcal disease can be ongoing suddenly, with high-grade fever, severe headache and vomiting. These symptoms can be easily done wrong for viral fever, dengue or malaria. If left undivided, the infection can progress rapidly for life-drank complications such as sepsis, encephalitis, seizures, and septic shock.

Dr. According to Soundaria M, Advisor -Pediatrics, KMC Hospital, Dr. Bribedkar Circle, Mangalore, these risks are fine that the meningococcal vaccine is being recommended.

Dr. Soundary explains that while the vaccine is not a full need for strong immune systems for all healthy children and adolescents, it is considered to be “good for vaccination” to suit India’s National Immunization Guidelines.

However, the vaccine is required for some high -risk groups. “Children with underlying chronic diseases, who are undergoing splanectomy, or on prolonged immunospressive therapy, should receive meningococcal vaccine,” she advises. In fact, many countries have included this vaccine in their regular national vaccination program.

The vaccine prevents the four major serogrops of the Vaccine Meningitidis -e, C, Y and W -135. Dr. Soundarya says that when children under two years are administered, it is given in two doses, in addition to three months. For individuals between 2 and 55 years of age, a single dose is sufficient. “The vaccine is generally safe, with only light localized reactions or low-grade fever in rare cases,” she says.

Manipal Hospital, Vijayawada Advisor General Physician Dr. Harika Upalapati says that meningococcal disease can be fatal in 10–15 percent of cases, even with antibiotic treatment. Of those who survive, 20 percent of them can experience prolonged effects such as hearing loss, seizures or brain damage.

To reduce these risks, CDC recommends regular meningococcal vaccinations for pretens, adolescents and other high-risk groups.

Dr. Vice -Chancellor outlines many population which are more vulnerable to meningococcal disease:

1. Functional or physical asplenia
2. People with sickle cell disease
3. HIV
4. People with frequent complement
5. Patient on medicines like Ekulijumab or Raoulizumab
6. People travel or live in local areas
7. Microbiologists regularly inform the Neeseria meningitidis
8. Routine Meningococcal ACWY is recommended for vaccination:
9. The first year college students live in the dormitory, who were not vaccinated or vaccinated before the age of 16 and it has been over five years.
10. Military recruitment
11. Adults aged 19-21 have not received the dosage of Manakvi since their 16th birthday.

Meningococcal disease can affect anyone but especially dangerous for infants, young children and adolescents. This can lead to life disability or death. “Vaccination remains the most effective means of conservation,” Dr. The vice -chancellor insisted.

The effectiveness of meningococcal vaccines varies:

• Polycecaride vaccines: 65% to 83.7% effective
• Conjugate vaccines: 66% to 100% effective

Now get the latest news with health and braking news and top headlines worldwide.